According to The Insight Partners, the Sex Hormones Market was valued at US$ 35.57 billion in 2025 and is expected to reach US$ 51.2 billion by 2034, recording a CAGR of 4.13% during 2026-2034. This growth reflects the continuing need for hormone-based treatments, expanding healthcare access, and increasing recognition of hormonal imbalances across different age groups. Pharmaceutical...